Trials / Withdrawn
WithdrawnNCT02624960
Safety and Performance of the AccuCinch® System
Safety and Performance of the AccuCinch® Ventricular Repair System
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ancora Heart, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, multi-center, open-label controlled study that will assess the safety and performance of the Accucinch System to induce left ventricular reverse remodeling and reduce the severity of functional mitral regurgitation in symptomatic adult patients with mitral regurgitation and left ventricular remodeling due to dilated cardiomyopathy (ischemic or non-ischemic etiology), who are of high operative risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Accucinch Implant | Percutaneous implantation of the Accucinch Implant in the mitral subannular space |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2019-03-01
- Completion
- 2019-09-01
- First posted
- 2015-12-09
- Last updated
- 2018-07-27
Source: ClinicalTrials.gov record NCT02624960. Inclusion in this directory is not an endorsement.